• HBC, Catalent Enter Innovative Softgel Alliance contractpharma
    May 13, 2021
    ​Hofseth BioCare ASA (HBC), a Norwegian biotech company that develops high-value ingredients and finished products, entered a global innovation partnership with Catalent to develop a delayed-release formulation of HBC’s OmeGo fish oil.
PharmaSources Customer Service